We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIIGW
1926
CALL
DELISTED
CIIG Capital Partners II, Inc. Warrant
CIIGW
| $717K | ﹤0.01% |
68,956
| – | – |
|
1927
PUT
Direxion Daily Energy Bull 2X ETF
ERX
$231M
| $716K | ﹤0.01% |
+12,300
| New | +$772K |
|
|
EGLE
1928
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $714K | ﹤0.01% |
15,699
-324,490
| -95% | -$17.3M |
|
|
GRMN
1929
Garmin
GRMN
$56.9B
| $713K | ﹤0.01% |
7,061
-306,515
| -98% | -$29.9M |
|
1930
Invesco S&P 500 Quality ETF
SPHQ
$19B
| $710K | ﹤0.01% |
+15,001
| New | +$686K |
|
1931
Cimpress
CMPR
$2.37B
| $709K | ﹤0.01% |
16,179
-44,584
| -73% | -$1.52M |
|
1932
Genesco
GCO
$434M
| $704K | ﹤0.01% |
19,100
-2,199
| -10% | -$96.4K |
|
1933
Actinium Pharmaceuticals
ATNM
$26.3M
| $703K | ﹤0.01% |
74,355
+51,896
| +231% | +$548K |
|
|
FAASW
1934
CALL
DELISTED
DigiAsia Corp Warrant
FAASW
| $701K | ﹤0.01% |
66,420
-133,575
| -67% | -$10.3K |
|
1935
Magnachip Semiconductor
MX
$110M
| $698K | ﹤0.01% |
+75,189
| New | +$745K |
|
|
RAIN
1936
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $693K | ﹤0.01% |
79,326
+42,647
| +116% | +$394K |
|
|
CCRD
1937
DELISTED
CoreCard
CCRD
| $692K | ﹤0.01% |
22,983
-1,565
| -6% | -$49.9K |
|
1938
James Hardie Industries
JHX
$15.2B
| $687K | ﹤0.01% |
31,715
-46,199
| -59% | -$979K |
|
1939
Maximus
MMS
$3.32B
| $687K | ﹤0.01% |
+8,723
| New | +$672K |
|
1940
Stantec
STN
$8.17B
| $686K | ﹤0.01% |
+11,753
| New | +$637K |
|
1941
Krystal Biotech
KRYS
$10.7B
| $686K | ﹤0.01% |
8,571
-3,629
| -30% | -$285K |
|
1942
Scholastic
SCHL
$774M
| $685K | ﹤0.01% |
20,018
-11,045
| -36% | -$471K |
|
|
AIV
1943
Aimco
AIV
$377M
| $684K | ﹤0.01% |
+88,921
| New | +$663K |
|
1944
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $680K | ﹤0.01% |
9,006
-30,871
| -77% | -$2.31M |
|
1945
Global X S&P 500 Covered Call ETF
XYLD
$3.19B
| $679K | ﹤0.01% |
+16,760
| New | +$675K |
|
1946
CALL
GDEV Inc Warrant
GDEVW
| $678K | ﹤0.01% |
98,969
-328,228
| -77% | -$80.6K |
|
1947
Simon Property Group
SPG
$76.4B
| $677K | ﹤0.01% |
+6,046
| New | +$722K |
|
|
SRTAW
1948
CALL
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
| $676K | ﹤0.01% |
200,000
| – | – |
|
1949
PG&E
PCG
$39B
| $674K | ﹤0.01% |
41,700
-556,646
| -93% | -$8.79M |
|
1950
Graham Corp
GHM
$1.03B
| $672K | ﹤0.01% |
+51,401
| New | +$625K |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.